These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10779030)

  • 61. Painless cholestatic jaundice in a 77-year-old woman.
    Visser H; Brumsen C; Kibbelaar R; Thompson J; Bieger R
    Ann Hematol; 1994 May; 68(5):261-5. PubMed ID: 8018769
    [No Abstract]   [Full Text] [Related]  

  • 62. Child with Jaundice and Pruritus: How to Evaluate?
    Jagadisan B; Srivastava A
    Indian J Pediatr; 2016 Nov; 83(11):1311-1320. PubMed ID: 26932879
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Severe jaundice in malignant lymphoma. Report of two autopsy cases.
    Sugimoto M; Mizukami H; Mao K; Aikawa K; Sadamoto T; Abei T
    Jpn J Med; 1986 Feb; 25(1):69-72. PubMed ID: 3712864
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature.
    Hu S; Bansal P; Lynch D; Rojas Hernandez CM; Dayao Z
    J Med Case Rep; 2016 Dec; 10(1):365. PubMed ID: 27998299
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Vanishing bile duct syndrome following allogeneic bone marrow transplantation].
    Aliani S; Meyer S; Krenn T; Müller-Molaian I; Graf N
    Klin Padiatr; 2002; 214(6):371-4. PubMed ID: 12424687
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [On jaundice during hemoblastosis. Lymphoreticulosarcomas].
    Bombara R; Cassi E; Pagliano F; Visca U
    Minerva Med; 1971 Feb; 62(12):553-6. PubMed ID: 4926824
    [No Abstract]   [Full Text] [Related]  

  • 67. [Liver involvement in patients with malignant lymphomas].
    Khadzhieva Zh; Gercheva L; Vasileva Z; Iordanova E
    Vutr Boles; 1989; 28(6):60-4. PubMed ID: 2633480
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differential diagnosis of jaundice in lymphoma patients.
    Birrer MJ; Young RC
    Semin Liver Dis; 1987 Aug; 7(3):269-77. PubMed ID: 3317863
    [No Abstract]   [Full Text] [Related]  

  • 69. A 10-year-old child presenting with syndromic paucity of bile ducts (Alagille syndrome): a case report.
    Pati GK; Singh A; Nath P; Narayan J; Padhi PK; Parida PK; Pattnaik K; Panda C; Singh SP
    J Med Case Rep; 2016 Nov; 10(1):342. PubMed ID: 27906097
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Primary non-Hodgkin's lymphoma of the common bile duct presenting as obstructive jaundice.
    Joo YE; Park CH; Lee WS; Kim HS; Choi SK; Cho CK; Rew JS; Kim SJ; Maetani I
    J Gastroenterol; 2004 Jul; 39(7):692-6. PubMed ID: 15293142
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Biliary tract obstruction secondary to malignant lymphoma: experience at a referral center.
    Odemiş B; Parlak E; Başar O; Yüksel O; Sahin B
    Dig Dis Sci; 2007 Sep; 52(9):2323-32. PubMed ID: 17406815
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Clinical and experimental study on hepatorenal syndrome in terms of obstructive jaundice (author's transl)].
    Kasai Y; Kawanishi N
    Hokkaido Igaku Zasshi; 1978; 53(2):147-55. PubMed ID: 352884
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Co-occurrence of cytomegalovirus-induced vanishing bile duct syndrome with papillary stenosis in HIV infection.
    Tyagi I; Puri AS; Sakhuja P; Majumdar K; Lunia M; Gondal R
    Hepatol Res; 2013 Mar; 43(3):311-4. PubMed ID: 23437911
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Idiopathic cholestasis in Hodgkin's disease].
    Parcero SA; Rubio RE; Huberman ED
    Acta Gastroenterol Latinoam; 1980; 10(4):283-9. PubMed ID: 7270014
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cholestatic jaundice as a paraneoplastic manifestation of renal cell carcinoma.
    Dourakis SP; Sinani C; Deutsch M; Dimitriadou E; Hadziyannis SJ
    Eur J Gastroenterol Hepatol; 1997 Mar; 9(3):311-4. PubMed ID: 9096437
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Meropenem-induced vanishing bile duct syndrome: A case report.
    Zubarev A; Haji K; Li M; Tiruvoipati R; Botha J
    J Int Med Res; 2020 Aug; 48(8):300060520937842. PubMed ID: 32865076
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Profile of hepatocyte apoptosis and bile lakes before and after bile duct decompression in severe obstructive jaundice patients.
    Lalisang TJ; Sjamsuhidajat R; Siregar NC; Taher A
    Hepatobiliary Pancreat Dis Int; 2010 Oct; 9(5):520-3. PubMed ID: 20943462
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Hepatic changes and jaundice in Hodgkin's disease].
    Gonzalez Cueto D; Pascuccelli H
    Medicina (B Aires); 1971; 31(4):255-66. PubMed ID: 5129002
    [No Abstract]   [Full Text] [Related]  

  • 79. Fatal vanishing bile duct syndrome in Iranian patient with Hodgkin's lymphoma.
    Shokri F; Shariati A; Veisari AK; Kianezhad A; Sheidaei S; Alamian AA; Sadeghi H; Heidary M
    Clin Case Rep; 2023 Jul; 11(7):e7671. PubMed ID: 37484745
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Vanishing bile duct syndrome in a patient with Hodgkin's lymphoma and asymptomatic hepatitis B virus infection.
    Umit H; Unsal G; Tezel A; Soylu AR; Pamuk GE; Turgut B; Demir M; Tucer D; Ermantas N; Cevikbas U
    Acta Gastroenterol Belg; 2009; 72(2):277-8. PubMed ID: 19637792
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.